{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:07:09Z","timestamp":1787069229218,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.eclinm.2024.102620","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T14:46:31Z","timestamp":1714747591000},"page":"102620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a\u00a0retrospective observational study"],"prefix":"10.1016","volume":"72","author":[{"given":"Wing Ming","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoey Cho","family":"Ting Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8821-780X","authenticated-orcid":false,"given":"Anthony Raymond","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi","family":"Kei Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Wai","family":"Yin Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-2538","authenticated-orcid":false,"given":"Ivan Fan","family":"Ngai Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102620_bib1","series-title":"WHO coronavirus (COVID-19) dashboard","year":"2023"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102620_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.46234\/ccdcw2022.071","article-title":"COVID-19 mortality and vaccine coverage - Hong Kong special administrative region, China, january 6, 2022-march 21, 2022","volume":"4","author":"Smith","year":"2022","journal-title":"China CDC Wkly"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102620_bib4","first-page":"82","article-title":"Impact of COVID-19 on the mortality of dialysis patients and kidney transplant recipients during the Omicron fifth wave in Hong Kong","volume":"29","author":"Chow","year":"2023","journal-title":"Hong Kong Med J"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102620_bib5","first-page":"173","article-title":"Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy","volume":"34","author":"Russo","year":"2021","journal-title":"J\u00a0Nephrol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102620_bib6","first-page":"69","article-title":"COVID-19 and chronic kidney disease: an updated overview of reviews","volume":"35","author":"Jdiaa","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.eclinm.2024.102620_bib7","series-title":"Fact sheet for healthcare providers: emergency use authorization for paxlovidtm","year":"2023"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102620_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102620_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10373","key":"10.1016\/j.eclinm.2024.102620_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102620_bib11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/ciad371","article-title":"Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with advanced chronic kidney disease and coronavirus disease 2019 (COVID-19)","volume":"77","author":"Chan","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102620_bib12","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/ndt\/gfad058","article-title":"Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure","volume":"38","author":"Cho","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102620_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.23876\/j.krcp.22.194","article-title":"Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease","volume":"42","author":"Dufour","year":"2023","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.eclinm.2024.102620_bib14","first-page":"00451","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"21","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102620_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/cid\/ciab989","article-title":"Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination","volume":"75","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102620_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","article-title":"Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong","volume":"81","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102620_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28068-3","article-title":"Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong","volume":"13","author":"Lai","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102620_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case\u2013control study","volume":"175","author":"Lai","year":"2022","journal-title":"Ann Int Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102620_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/joim.13453","article-title":"Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection","volume":"291","author":"Lai","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.eclinm.2024.102620_bib20","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1136\/gutjnl-2021-326860","article-title":"Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2024.102620_bib21","article-title":"Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study","volume":"21","author":"Wan","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102620_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.2021.0684","article-title":"Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study","volume":"32","author":"Xiong","year":"2022","journal-title":"Thyroid"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102620_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of public health research\u2014strengthening causal inference from observational data","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102620_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102620_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eclinm.2024.102620_bib26","article-title":"Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study","volume":"43","author":"Yang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.eclinm.2024.102620_bib27","series-title":"Fact sheet for healthcare providers: emergency use authorization for LagevrioTM (molnupiravir) capsules","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102620_bib28","series-title":"Fact sheet for healthcare providers: emergency use authorization for PaxlovidTM","year":"2023"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102620_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"15","key":"10.1016\/j.eclinm.2024.102620_bib30","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102620_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102620_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia pacific association of study of liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102620_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"24","key":"10.1016\/j.eclinm.2024.102620_bib34","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.3748\/wjg.v25.i24.2990","article-title":"Application of Big Data analysis in gastrointestinal research","volume":"25","author":"Cheung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102620_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Int Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102620_bib36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cpt.2688","article-title":"Pharmacokinetics of oral nirmatrelvir\/ritonavir, a protease inhibitor for treatment of COVID-19, in subjects with renal impairment","volume":"112","author":"Toussi","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102620_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01229-22","article-title":"Pharmacokinetics of nirmatrelvir and ritonavir in COVID-19 patients with end-stage renal disease on intermittent hemodialysis","volume":"66","author":"Lingscheid","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102620_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.115969","article-title":"Nirmatrelvir\/ritonavir use in patients with COVID-19 on hemodialysis: a case series","volume":"107","author":"Zhang","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102620_bib39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.05270522","article-title":"Prescribing nirmatrelvir\/ritonavir for COVID-19 in advanced CKD","volume":"17","author":"Hiremath","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102620_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2215\/CJN.0000000000000107","article-title":"Early experience with modified dose nirmatrelvir\/ritonavir in dialysis patients with coronavirus disease 2019","volume":"18","author":"Hiremath","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.eclinm.2024.102620_bib41","series-title":"Therapeutic brief: crushing nirmatrelvir\/ritonavir (paxlovid). 2022 4 July","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102620_bib42","series-title":"Interim recommendation on clinical management of adult cases with coronavirus disease 2019 (COVID-19) version 2.4","year":"2024"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102620_bib43","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/v14112519","article-title":"Evolution and control of COVID-19 epidemic in Hong Kong","volume":"14","author":"Wong","year":"2022","journal-title":"Viruses"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T11:23:05Z","timestamp":1720351385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"alternative-id":["S2589537024001998"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102620","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a\u00a0retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102620"}}